Open Orphan plc announced a further contract renewal with a major top-3 global pharmaceutical client extending its consultancy services to end of December 2021. This follows on from the announcement made on 22 December 2020 regarding the same client and demonstrates the repeat business that Venn Life Sciences continues to win from its long-term clients. The Venn team in the Breda office in the Netherlands, will provide Chemistry, Manufacturing & Control consultancy services to this leading global pharmaceutical client for one of the client's vaccine development programmes and follows the recently announced contract renewal for work on two of the client's vaccine development programmes. This successful collaboration has been extended until end of December 2021.